Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
- Posted on April 20, 2026
- By Google News
- 0 Views
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Kelonia Therapeutics, Inc. ("Kelonia"), a clinical-stage biotechnology company pioneering in vivo gene...
